Co-Authors
This is a "connection" page, showing publications co-authored by SUSAN HILSENBECK and ANNA MALOVANNAYA.
Connection Strength
0.281
-
Integrative proteogenomics and forward genetics reveals a novel mitotic vulnerability in triple-negative breast cancer. Cancer Discov. 2025 Aug 11.
Score: 0.062
-
Patient-Derived Xenografts of Triple-Negative Breast Cancer Enable Deconvolution and Prediction of Chemotherapy Responses. bioRxiv. 2025 Jan 08.
Score: 0.059
-
Targeting eIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer. J Clin Invest. 2023 12 15; 133(24).
Score: 0.055
-
Targeting EIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer. bioRxiv. 2023 Sep 28.
Score: 0.054
-
Identifying biomarkers of differential chemotherapy response in TNBC patient-derived xenografts with a CTD/WGCNA approach. iScience. 2023 Jan 20; 26(1):105799.
Score: 0.051